Michael Patrick Dillon
56Patents
5h-index
105Co-inventors
75Inventor score
Filing activity: Feb 1, 1999 → Jan 5, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7531547B2 | Diaminopyrimidines as P2X3 and P2X2/3 modulators | Human Necessities | 31 | Active |
| US7858632B2 | Diaminopyrimidines as P2X3 and P2X2/3 antagonists | Human Necessities | 15 | Active |
| US6319920A | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives | Chemistry; Metallurgy | 11 | Expired |
| US8008313B2 | Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases | Human Necessities | 6 | Active |
| US7491821B2 | Inhibitors of P2X3 | Chemistry; Metallurgy | 6 | Active |
| US9694016B2 | Biaryl amide compounds as kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8268840B2 | Pyrimidinyl pyridone inhibitors of kinases | Human Necessities | 5 | Active |
| US7799796B2 | Diaminopyrimidines as P2X3 and P2X2/3 modulators | Chemistry; Metallurgy | 5 | Active |
| US8846705B2 | Diaminopyrimidines as P2X3 and P2X2/3 antagonists | Human Necessities | 4 | Active |
| US7595405B2 | Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Chemistry; Metallurgy | 4 | Active |
| US6355641B1 | Oxazolone derivatives and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US10710980B2 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US7786110B2 | Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Chemistry; Metallurgy | 3 | Active |
| US10815250B2 | AhR modulators | Chemistry; Metallurgy | 3 | Active |
| US10709712B2 | Biaryl amide compounds as kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10245267B2 | Biaryl amide compounds as kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US7470684B2 | Spiropiperidine derivatives as NK3 antagonists | Human Necessities | 3 | Active |
| US10947218B2 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US8048905B2 | Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Chemistry; Metallurgy | 2 | Active |
| US7776872B2 | Diaminopyrimidines as P2X3 and P2X2/3 modulators | Chemistry; Metallurgy | 2 | Active |
| US10167279B2 | Compounds and compositions as RAF kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8841336B2 | Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Chemistry; Metallurgy | 1 | Active |
| US7589090B2 | Diaminopyrimidines as P2X3 and P2X2/3 modulators | Chemistry; Metallurgy | 1 | Active |
| US8119644B2 | Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Chemistry; Metallurgy | 1 | Active |
| US8501933B2 | Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.